Immuno-oncology's evolution: implications for pharma market researchers

Presented by

Dominic Tyer

About this talk

Immuno-oncology therapies that harness the body’s own defences to fight tumours are widely acknowledged as the new frontier in cancer treatment, but until recently only a few products had reached the market for a limited number of indications. Over the past 12 months several new products have been approved for a wider range of tumour types and with pipelines boasting numerous other products in the area, competition looks set to hot up. On November 17 Research Partnership, in association with PMGroup, will host a free webinar which will explore the key features of the immuno-oncology market and the critical success factors for remaining competitive. I would like to invite you to register for the webinar - either to watch it live on the day or for access to a recorded version.

Related topics:

More from this channel

Upcoming talks (0)
On-demand talks (51)
Subscribers (7856)
This is a new service from PMGroup, who will be known to many in the pharmaceutical and healthcare industries for its well established portfolio of publications, awards schemes, live events and online offerings. Join us on our webinars to get connected with other thought leaders in healthcare